Intellectual Property: patents (contentious & non-contentious) - "Andrew has been identified as a key name to note."
Andrew is a partner in the Patents & Innovation team and offers expert counsel on contentious patent and regulatory matters.
Leveraging his previous experience as a medicinal chemist in the pharmaceutical industry, he is particularly focused on advising companies within the life sciences sector and is recognised by clients for his extensive industry knowledge.
Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128
Patents Overhauled: Impact of the America Invents Act on the Pharmaceutical Industry (co-author), European Biopharmaceutical Review, Spring 2015
New and Approved: The New EU Clinical Trials Regulation (co-author), European Pharmaceutical Contractor, December 2014 p 50-53
Intellectual Property: patents (contentious & non-contentious) - "Andrew has been identified as a key name to note."
作者
Brexit and beyond – Wellcome's recommendations from the Future Partnership Project
作者 Andrew Payne
作者 Sophia Louw 以及 Natalia Faekova
作者
作者 Alison Dennis 以及 Alice Matthews
作者